Cargando…
Glycogen synthase kinase‐3β is a pivotal mediator of cancer invasion and resistance to therapy
Tumor cell invasion and resistance to therapy are the most intractable biological characteristics of cancer and, therefore, the most challenging for current cancer research and treatment paradigms. Refractory cancers, including pancreatic cancer and glioblastoma, show an inextricable association bet...
Autores principales: | Domoto, Takahiro, Pyko, Ilya V., Furuta, Takuya, Miyashita, Katsuyoshi, Uehara, Masahiro, Shimasaki, Takeo, Nakada, Mitsutoshi, Minamoto, Toshinari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084660/ https://www.ncbi.nlm.nih.gov/pubmed/27486911 http://dx.doi.org/10.1111/cas.13028 |
Ejemplares similares
-
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020) -
Glycogen synthase kinase‐3β participates in acquired resistance to gemcitabine in pancreatic cancer
por: Uehara, Masahiro, et al.
Publicado: (2020) -
Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma
por: Bolidong, Dilireba, et al.
Publicado: (2020) -
Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma
por: Furuta, Takuya, et al.
Publicado: (2017) -
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)